Biotinyl-Angiotensin I/II (1-7) presents a heptapeptide derived from the Angiotensin system with an added biotin handle for affinity techniques. The sequence preserves key residues important for receptor interaction and enzyme recognition. Its modification allows surface immobilization and detection without disrupting core motifs. Researchers employ it in binding-profile analysis, enzymatic processing studies, and ligand-screening assays.
CAT No: A15086
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More